Metformin inhibits chronic kidney disease‐induced DNA damage and senescence of mesenchymal stem cells

Mesenchymal stem cells (MSCs) are promising source of cell‐based regenerative therapy. In consideration of the risk of allosensitization, autologous MSC‐based therapy is preferred over allogenic transplantation in patients with chronic kidney disease (CKD). However, it remains uncertain whether adeq...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Hyoungnae, Yu, Mi Ra, Lee, Haekyung, Kwon, Soon Hyo, Jeon, Jin Seok, Han, Dong Cheol, Noh, Hyunjin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7884040/
https://www.ncbi.nlm.nih.gov/pubmed/33524231
http://dx.doi.org/10.1111/acel.13317

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7884040/
https://www.ncbi.nlm.nih.gov/pubmed/33524231
http://dx.doi.org/10.1111/acel.13317

Ejemplares similares